Ansell Limited (ANSLF)

Ansell Limited (ANSLF) Healthcare & Pipeline Overview

Ansell Limited is a global leader in protection solutions, specializing in the design and manufacture of essential healthcare and industrial safety products. With a broad portfolio including surgical gloves and chemical protective clothing, the company serves critical sectors worldwide, leveraging over a century of experience and a robust international distribution network.

What Is the Investment Thesis for ANSLF?

Ansell Limited presents a resilient investment profile, underpinned by its essential product offerings across critical Healthcare and Industrial segments globally. The company's stable financial metrics, including a P/E ratio of 20.6, a solid Profit Margin of 6.7%, and a robust Gross Margin of 41.9%, indicate efficient operations and profitability within its specialized markets. A low Beta of 0.55 suggests lower volatility compared to the broader market, appealing to investors seeking stability. Furthermore, its 2.75% Dividend Yield offers consistent income. Growth catalysts include ongoing global demand for personal protective equipment in healthcare, driven by demographic shifts and increased health awareness, alongside rising industrial safety standards worldwide. Ansell's extensive geographic reach across Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America provides diversified revenue streams and opportunities for expansion into emerging markets. The company's long operating history since 1893 and continuous product innovation reinforce its market position and ability to adapt to evolving safety requirements, driving long-term value.

Based on FMP financials and quantitative analysis

ANSLF Key Highlights

• Market Capitalization: $3.28 billion, reflecting its substantial presence in the global protection solutions market.
• Price-to-Earnings (P/E) Ratio: 20.62, indicating investor confidence in its earnings power relative to its share price.
• Gross Margin: 41.9%, demonstrating strong profitability on its core product sales before operating expenses.
• Profit Margin: 6.7%, showcasing efficient management of costs to generate net income from its global operations.
• Dividend Yield: 2.75%, providing a consistent return to shareholders, indicative of a mature and stable business.

Who Are ANSLF's Competitors?

ANSLF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ANSLF's Key Strengths?

• Global presence across diverse geographic regions and markets.
• Dual-segment business model (Healthcare and Industrial) provides diversification.
• Long operating history since 1893, indicating resilience and experience.
• Comprehensive product portfolio meeting critical safety needs.
• Strong gross margin of 41.9% reflecting efficient production and pricing power.

What Are ANSLF's Weaknesses?

• Reliance on specific raw materials, potentially exposing it to price volatility.
• OTC market listing may limit liquidity and investor access compared to major exchanges.
• Potential for intense competition from both specialized and diversified manufacturers.
• Disclosure status on OTC market is "Unknown," which can deter some investors.

What Could Drive ANSLF Stock Higher?

• Global demand for personal protective equipment (PPE) continues to rise, driven by heightened health awareness and industrial safety regulations.
• Potential for new product innovations in specialized protective solutions to address evolving market needs and differentiate offerings.
• Expansion into new geographic markets, particularly in developing regions with growing healthcare infrastructure and industrialization.
• Increased adoption of stringent workplace safety standards across various industrial sectors globally, boosting demand for Ansell's protective clothing.
• Strategic partnerships or acquisitions that could expand Ansell's product portfolio or market reach in key segments.

What Are the Key Risks for ANSLF?

• Disruptions in global supply chains could impact the availability of raw materials or the timely delivery of finished products.
• Intense competition from both established global players and emerging manufacturers in both the Healthcare and Industrial segments.
• Economic downturns or recessions could reduce industrial activity, thereby decreasing demand for protective clothing and impacting revenue.
• Fluctuations in currency exchange rates could negatively affect Ansell's international revenues and profitability, given its global operations.
• Regulatory changes in healthcare or industrial safety standards could necessitate costly product redesigns or compliance efforts.

What Are the Growth Opportunities for ANSLF?

• Expansion in Emerging Healthcare Markets: Ansell has a significant opportunity to expand its presence in rapidly developing healthcare markets across Asia Pacific, Latin America, and parts of Africa. These regions are experiencing substantial growth in healthcare infrastructure, increased access to medical services, and a rising focus on infection control and patient safety. By leveraging its established global supply chains and product expertise, Ansell can capture market share for surgical, examination, and single-use gloves, addressing the growing demand from new hospitals, clinics, and life sciences facilities. This expansion could involve strategic partnerships or localized manufacturing to cater to specific regional needs and regulatory environments.
• Increased Demand for Industrial Safety Solutions: The global industrial sector continues to face evolving safety regulations and a heightened emphasis on worker protection, particularly in high-risk industries like chemical, mining, oil and gas, and construction. Ansell's Industrial segment, which provides hand and chemical protective clothing, is well-positioned to benefit from this trend. As industries adopt more rigorous safety protocols and seek advanced protective solutions, Ansell can drive growth through product innovation, offering specialized gear that meets specific industry challenges and compliance requirements, thereby securing larger contracts and expanding its market penetration.
• Product Innovation in Specialized Protective Gear: Continuous research and development into advanced materials and ergonomic designs for protective solutions represent a significant growth avenue. In the Healthcare segment, this could involve developing next-generation gloves with enhanced barrier protection, improved tactile sensitivity, or sustainable materials. For the Industrial segment, innovation might focus on smart PPE with integrated sensors, multi-hazard protection, or lighter, more comfortable designs that encourage compliance. These innovations can differentiate Ansell's offerings, command premium pricing, and open new market niches, reinforcing its position as a technology leader in protection solutions.
• Leveraging Global Distribution Network for Niche Markets: Ansell's extensive global distribution network, spanning multiple continents, provides a robust platform for entering and expanding into niche, high-value protection markets. Beyond its core offerings, the company can identify specific sub-segments within healthcare (e.g., specialized laboratory gloves for advanced research) or industrial applications (e.g., protective gear for renewable energy sector workers) where its expertise and reach can be uniquely leveraged. This strategy allows for targeted marketing and sales efforts, optimizing existing infrastructure to capture specialized demand without requiring significant new capital expenditure.
• Strategic Acquisitions and Partnerships: Given its established market position and financial strength, Ansell has the opportunity to pursue strategic acquisitions of smaller, innovative companies or forge partnerships that complement its existing product lines or expand its technological capabilities. Acquiring specialized manufacturers could bring new intellectual property, enhance market access in specific geographies, or diversify its product portfolio into adjacent protective solution categories. Such inorganic growth strategies can accelerate market penetration, consolidate competitive advantages, and provide immediate access to new customer bases or technologies.

What Opportunities Does ANSLF Have?

• Growing global demand for personal protective equipment (PPE) in healthcare.
• Increasing industrial safety regulations driving demand for protective clothing.
• Expansion into emerging markets with developing healthcare and industrial sectors.
• Innovation in product materials and design for enhanced protection and comfort.

What Threats Does ANSLF Face?

• Economic downturns impacting industrial production and demand for safety gear.
• Supply chain disruptions or geopolitical events affecting global operations.
• Intense price competition from lower-cost manufacturers.
• Changes in regulatory standards requiring costly product redesigns or certifications.

What Are ANSLF's Competitive Advantages?

• Global Brand Recognition and Trust: Over a century of operation (founded 1893) has built a strong, trusted brand name in critical safety and protection markets worldwide.
• Extensive Product Portfolio: A comprehensive range of specialized gloves and protective clothing caters to diverse and specific needs across both healthcare and industrial sectors, making it a one-stop solution for many clients.
• Global Distribution and Manufacturing Footprint: Broad geographic reach across multiple continents allows for efficient supply chain management and market penetration, creating barriers for new entrants.
• Regulatory Compliance and Quality Standards: Adherence to stringent global healthcare and industrial safety regulations, coupled with a focus on high-quality manufacturing, ensures product reliability and customer loyalty in critical applications.
• Dual-Segment Diversification: Operating in both Healthcare and Industrial segments provides diversification against downturns in any single market, leveraging essential demand in both sectors.

What Does ANSLF Do?

Ansell Limited, founded in 1893 and headquartered in Richmond, Australia, has evolved into a global leader in the design, development, and manufacture of advanced protection solutions. Initially known as Pacific Dunlop Limited, the company rebranded to Ansell Limited in 2002, marking a strategic focus on its core protective solutions business. With a workforce of 15,000 employees, Ansell operates across vast geographic regions including Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America, establishing a significant international footprint. The company's operations are strategically divided into two primary segments: Healthcare and Industrial. The Healthcare segment is dedicated to producing and marketing a comprehensive range of solutions vital for medical and life sciences professionals. This includes specialized surgical gloves, versatile single-use and examination gloves, and meticulously clean and sterile gloves and garments. These products are indispensable for a diverse client base, encompassing hospitals, surgical centers, dental practices, veterinary clinics, first responders, laboratories, and companies within the life sciences and pharmaceutical sectors. Ansell's commitment to quality and innovation in this segment addresses critical needs for infection control, personal protection, and operational efficiency in sensitive environments. The Industrial segment focuses on manufacturing and marketing hand and chemical protective clothing solutions designed for a multitude of demanding industrial applications. This segment serves a broad spectrum of industries, including automotive, chemical processing, metal fabrication, machinery and equipment manufacturing, food processing, construction, mining, oil and gas, and first responders. Ansell's protective clothing solutions are engineered to safeguard workers against various hazards, from chemical exposure to mechanical risks, thereby enhancing workplace safety and compliance. Through its subsidiary, P. D. Holdings Pty. Ltd., Ansell continues to reinforce its operational structure and market reach, solidifying its position as a critical provider of safety solutions globally.

What Products and Services Does ANSLF Offer?

• Designs and develops a wide range of protection solutions for various industries.
• Manufactures surgical gloves, single-use, and examination gloves for healthcare.
• Produces clean and sterile gloves and garments for medical and life sciences applications.
• Creates hand and chemical protective clothing for industrial use.
• Serves hospitals, surgical centers, dental practices, veterinary clinics, and first responders.
• Supplies laboratories, life sciences, and pharmaceutical companies with protective consumables.
• Provides safety solutions for automotive, chemical, metal fabrication, and machinery industries.
• Supports food processing, construction, mining, oil and gas sectors with protective gear.

How Does ANSLF Make Money?

• Generates revenue through the design, manufacture, and global sale of protective solutions.
• Operates through two primary segments: Healthcare and Industrial, each with distinct product lines and customer bases.
• Utilizes a global distribution network to reach customers across Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America.
• Focuses on providing essential, high-quality safety products that meet stringent industry standards and regulatory requirements.
• Leverages a long-standing brand reputation and expertise in materials science to differentiate its offerings.

What Industry Does ANSLF Operate In?

Ansell Limited operates within the Medical - Instruments & Supplies industry, a critical component of the broader Healthcare sector, while also maintaining a strong presence in industrial safety. This industry is characterized by continuous demand for essential protective equipment, driven by stringent regulatory standards, growing health consciousness, and increasing industrial activity globally. Ansell's dual-segment approach, encompassing both healthcare and industrial protection solutions, positions it uniquely to capitalize on diverse market trends. The competitive landscape includes both specialized manufacturers and larger diversified conglomerates. Ansell differentiates itself through its extensive product portfolio, global distribution network, and a long-standing reputation for quality and innovation in specialized protective gear. Market trends indicate sustained growth in demand for personal protective equipment (PPE) across both segments, fueled by factors such as an aging global population, heightened awareness of infectious diseases, and stricter workplace safety regulations in industrial settings.

Who Are ANSLF's Key Customers?

• Hospitals, surgical centers, and dental practices requiring sterile and examination gloves.
• Veterinary clinics and first responders needing reliable protective equipment.
• Laboratories, life sciences, and pharmaceutical companies utilizing clean and sterile consumables.
• Automotive, chemical, metal fabrication, and machinery and equipment manufacturers.
• Food processing, construction, mining, and oil and gas industries.
• First responders in industrial settings requiring chemical protective clothing.

Company Profile

Ansell Limited operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Richmond, AU. The company is led by CEO Nathalie Ahlstrom. ANSLF has traded publicly since 2010.

Ansell Limited Financial Trajectory

Ansell Limited (ANSLF) reported $1.05B in revenue for Q4 2025, reflecting 2.5% growth compared to the prior quarter. The company recorded net income of $90.4M, with diluted EPS of $0.62. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this mid-cap Healthcare company. Across the four most recent quarters, ANSLF averaged $0.43 in diluted EPS.

How Ansell Limited Is Valued

Ansell Limited carries a market capitalization of $2.77B, placing it in the mid-cap category. Relative to its peer group, ANSLF's quantitative score of 57/100 is roughly in line with the peer average of 63/100.

ROE 7%Key Financial Metrics

Return on equity for Ansell Limited stands at 7.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.2%, showing how much profit it generates from its asset base. ANSLF trades at a trailing price-to-earnings ratio of 20.62, below the Healthcare sector average of ~23x. Its free cash flow yield is 6.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.36 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 4.8%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 6/9Financial Health

Ansell Limited's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 3.56 places it in the safe zone, indicating low near-term bankruptcy risk.

FY2026 estForward Outlook

Wall Street analysts project Ansell Limited revenue of about $2.08B for fiscal 2026, with EPS near $1.45. The estimate reflects 11 contributing analysts.

ANSLF Financials

ANSLF Latest News

ANSLF Analyst Consensus

ANSLF MoonshotScore

Common Questions About ANSLF (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources